Detection of digitalis compounds using a surface plasmon resonance- based biosensor

Biosensors and Bioelectronics

Volumn 13, Issue 10, 1998, Pages 1055-1060

  Laricchia Robbio, Leopoldo ^a   Balzan, Silvana ^b   Ghione, Sergio ^b   Montali, Umberto ^c   Revoltella, Roberto P ^a  

^a CNR   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Antiouabain antibodies; BIA technology; Endogenous digitalis like factor; RIA

Indexed keywords

ANTIBODIES; DRUG PRODUCTS; MOLECULAR DYNAMICS;

ENDOGENOUS DIGITALIS-LIKE FACTORS; EXOGENOUS DIGITALIS-LIKE FACTORS; SURFACE PLASMON RESONANCE;

BIOSENSORS;

DIGITALIS; OUABAIN;

ARTICLE; AUTOMATION; BIOSENSOR; DRUG DETERMINATION; HUMAN; HYPERTENSION; TECHNOLOGY; UMBILICAL CORD BLOOD;

EID: 0032213111     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0956-5663(98)00065-7     Document Type: Article

References (27)

1. + ATPase inhibition during voluntary hypoventilation. Hypertension. 26:1995;781-788.
2. Balzan S., Montali U., Genovesi-Ebert A., Biver P., Fantoni M., Ghione S. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma. Clin. Sci. 77:1989;375-381.
3. Balzan S., Montali U., Di Bartolo V., Ghione S. Further evidence for an endogenous digitalis-like compound in newborn and adult plasma detected by anti-ouabain antiserum. Life Sci. 60:1997;893-898.
4. Di Bartolo V., Balzan S., Pieraccini L., Ghione S., Pegoraro S., Biver P., Revoltella R., Montali U. Evidence for an endogenous ouabain-like immunoreactive factor in human plasma coeluted with ouabain on HPLC. Life Sci. 57:1995;1417-1425.
5. Doris P.A., Jenkins L.A., Stocco D.M. Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension. 23:1994;632-638.
6. Fägerstam L. A non-label technology for real-time biospecific interaction analysis. Tech. Protein Chem. 2:1991;65-71.
7. Fägerstam L., Frostell-Karlsson A., Karlsson R., Persson B., Rönnberg I. Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J. Chromatography. 597:1992;397-403.
8. Ferrandi, M., Manuta, P., Balzan, S., Bianchi, G., Ferrari, P., 1997. Endogenous ouabain is detectable in mammalian tissues and plasma, Hypertension, in press.
9. Goto A., Yamada K., Yagi N., Yoshioka M., Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol. Rev. 44:1992;377-399.
10. Goto A., Yamada K., Yagi N., Hui C., Nagoshi H., Sasabe M., Yoshioka M. Digitalis-like factors from human urine. J. Cardiovasc. Pharmacol. 22:1993;160-2246.
11. Gottlieb S.S., Rogowski A.C., Weinberg M., Krichten C.M., Hamilton B.P., Hamlyn J.M. Elevated concentrations of endogenous ouabain in patients with congestive heart failure [see comments]. Circulation. 86:1992;420-425.
12. Hamlyn J.M., Hamilton B.P., Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J. Hypertens. 14:1996;151-167.
13. Jönsson B., Löfas S., Lindquist G. Immobilization of proteins to carboxy methyl-dextran-modified gold surface for biospecific analysis in surface plasmon resonance sensors. Anal. Biochem. 198:1991;268-277.
14. Jönsson U., Malmqvist M. Real time biospecific interaction analysis. Adv. Biosensor. 2:1992;291-336.
15. Laricchia-Robbio L., Liedberg B., Platou-Vikinge T., Rovero P., Beffy P., Revoltella R. Mapping of monoclonal antibody and receptor binding domains on human granulocyte-macrophage colony stimulating factor (rhGM-CSF) using a surface plasmon resonance-based biosensor. Hybridoma. 15:1996;343-350.
16. Laricchia-Robbio L., Moscato S., Guidi A., Viganò S., Rovero P., Revoltella R. Detection and epitope mapping of immunoreactive human endothelin-1 using ELISA and a surface plasmon resonance-based biosensor. Biosens. Bioelectron. 12:1997;765-778.
17. Lewis L., Yandle T., Lewis J., Richards A., Pidgeon G., Kaaja R., Nicholls M. Ouabain is not detectable in human plasma. Hypertension. 24:1994;549-555.
18. Liedberg B., Nylander C., Lundström I. Surface plasmon resonance for gas detecting and biosensing. Sensors and Actuators. 4:1983;299-304.
19. Liedberg B., Lundström I., Stenberg E. Principles of biosensing with an extended coupling matrix and surface plasmon resonance. Sensors and Actuators. 11:1993;63-72.
20. Ludens J.H., Clark M.A., DuCharme D.W., Harris D.W., Lutzke B.S., Mandel F., Mathews W.R., Sutter D.M., Hamlyn J.M. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension. 17:1991;923-929.
21. Masugi F., Ogihara T., Hasegawa T., Kumahara Y. Ouabain-like and non-ouabain-like factors in plasma of patients with essential hypertension. Clin. Exp. Hypertens. A9:1987;1233-1242.
22. Montali U., Balzan S., Ghione S. Purification of endogenous digitalis-like factor(s) from cord blood of neonate by immunoaffinity chromatography. Biochem. Int. 25:1991;853-859.
23. Naruse K., Naruse M., Tanabe A., Yoshimoto T., Watanabe Y., Kurimoto F., Horiba N., Tamura M., Inagami T., Demura H. Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension. 23:1994;194-911x.
24. Sich B., Kirch U., Tepel M., Zidek W., Schoner W. Pulse pressure correlates in humans with a proscillaridin a immunoreactive compound. Hypertension. 27:1996;1073-1078.
25. Sjölander S., Urbaniczky C. Integrated fluid handeling system for biololecular interaction analysis. Anal. Chem. 63:1991;2338-2345.
26. Yamada K., Goto A., Hui C., Yagi N., Nagoshi H., Sasabe M., Sugimoto T. Role of ouabainlike compound in rats with reduced renal mass-saline hypertension. Am. J. Physiol. 266:1994;H1357-H1362.
27. Zhao N., Lo L.C., Berova N., Nakanishi K., Tymiak A.A., Ludens J.H., Haupert G.T. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry. 34:1995;9893-9896.